Merck sells its $175 million investment stake in Moderna after recording a 'substantial' gain (MRNA)Business Insider • 12/02/20
Moderna, Inc. (MRNA) CEO Stéphane Bancel Presents at Piper Sandler 32nd Annual Virtual Healthcare Conference (Transcript)Seeking Alpha • 12/02/20
Moderna, Inc. (MRNA) Presents at Evercore ISI HealthCONx Broker Conference Call - (Transcript)Seeking Alpha • 12/01/20
European Drug Regulator Gives 6-Week Time Frame For Opinions On Pfizer-BioNTech, Moderna COVID-19 VaccinesBenzinga • 12/01/20
Europe May Not Get Covid-19 Vaccine Before 2021, Earliest Approval Process Scheduled For December 29Forbes • 12/01/20
Moderna's Coronavirus Vaccine to Be Reviewed by FDA Advisory Committee on Dec. 17The Motley Fool • 12/01/20
Moderna Hits A Record High As It Seeks FDA OK For Coronavirus VaccineInvestors Business Daily • 11/30/20